|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 12-08-2004
WASHINGTON (Reuters) - A new type of breast cancer drug is clearly superior to the old standard, tamoxifen, in many women and should now be the first drug used to treat the cancer, U.S. and British researchers said on Wednesday.
NEW YORK (Reuters Health) - Janet Jackson's wardrobe malfunction may have grabbed the most attention at the last Super Bowl, but a new study puts the spotlight on children's exposure to violence in commercials aired during that and other major sporting events.
NEW YORK (Reuters) - U.K. regulators have extended the suspension of Chiron Corp.'s influenza vaccine production in Liverpool, England for another three months from Jan. 4, the company said on Tuesday.
NEW YORK (Reuters Health) - First-degree relatives of alcoholics are more likely to also become addicted to alcohol, as well as to other drugs such as cocaine, according to new research.
CHICAGO (Reuters) - Bigger babies are not guaranteed to grow into healthier adults when it comes to cholesterol levels and related heart disease problems, a study said on Tuesday.
NEW YORK (Reuters Health) - Being overweight can speed the progression of knee osteoarthritis, but the effect may be limited to people who are moderately "bowlegged" or "knock-kneed," a new study suggests.
CHICAGO (Reuters) - Younger Americans who are overweight today are threatening to hit the U.S. government's Medicare system with big health care bills when they reach old age, according to a report published on Tuesday.
HONG KONG (Reuters) - Scientists in Hong Kong and China said on Wednesday they have developed a test to detect bird flu infections in humans within hours, which could give health officials an important tool for controlling the killer virus.
CHICAGO (Reuters) - Lifetime exposure to lead from paint in older houses, drinking water pipes and other sources appears to increase men's risk of cataract development, researchers reported on Tuesday.
LOS ANGELES (Reuters) - Drug maker Merck & Co. Inc. on Tuesday said its board appointed a committee to review the company's actions prior to the voluntary withdrawal of its painkiller Vioxx.
|
|
